Tubal Precursor Lesions for High-Grade Serous Ovarian Carcinoma

被引:0
|
作者
Meleis, Mahmoud Hanafy [1 ]
El-Agwany, Ahmed Mohammed Samy [1 ]
机构
[1] Alexandria Univ, El Shatby Matern Univ Hosp, Fac Med, Dept Obstet & Gynecol, Alexandria, Egypt
关键词
Serous carcinoma; Ovarian cancer; P53; Immunostaining; Peritoneal cancer; BRCA1; BRCA2;
D O I
10.1007/s40944-015-0031-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Ovarian cancer is the most common fatal cancer of the female reproductive tract in industrialized countries; it is diagnosed annually in more than 200,000 women worldwide, with the greatest incidence in the USA and Northern Europe, and lowest incidence in Africa and Asia. Aim of the work To show whether the fallopian tube could be the site of origin of pelvic carcinomas. Patients This study included 36 patients with high-grade serous ovarian carcinoma. The patients were selected from the Gynecology Clinic in El-shatby University Maternity Hospital. All patients underwent laparotomy for cytoreduction and staging in Gynecology Department, and all biopsies were sent for histopathology, and patients diagnosed to be high-grade serous ovarian carcinoma were included in our study. Inclusion criteria were high-grade serous-type ovarian cancer selected after laparotomy and histopathological examination. Exclusion criteria were benign adnexal mass, low-grade tumor and other types of ovarian tumors. Methods All patients were subjected to preoperative analysis (history taking, clinical evaluation, ultrasound abdomen and pelvis, for estimation of morphological index, CT scan, assessment of CT peritoneal cancer index PCI and Serum CA125 assessment). Intraoperative peritoneal wash or ascites fluid aspiration, total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy, either supra-or infra-colonic and lymphadenectomy (pelvic, para-aortic) if suspicious were done, and pathological examination (gross examination and histopathological examination) and immunostaining were done. Results Histopathological diagnosis of the tubal lesions through examination of the H& E sections of the distal part of the tube in the studied groups revealed either normal tube with no remarkable changes, hyperplastic changes or tubal intraepithelial neoplasia. In the serous group, 21.4 % of the cases were normal, 69.6 % showed hyperplastic changes, and 9 % were TIN. The non-serous group showed 30.8 % of the cases were normal, 69.2 % showed hyperplastic changes, and no one showed TIN. While the control group showed 83.3 % were normal, 16.7 % showed hyperplastic changes and no one showed TIN. There was a significant difference between serous and control as well as between non-serous and control. In the low-grade group, about 11.1 % of the cases showed no pathological changes, 89.9 % showed hyperplastic changes, and no one showed TIN. While in the high-grade group, 26.3 % of the cases showed no pathological changes, 60.5 % showed hyperplastic changes, and 13.2 % showed TIN. The difference between high-and low-grade serous tumors was statistically significant. Results of immunohistochemical staining for P53 in tubal sections revealed that in the serous group, 5 cases (8.9 %) showed negative staining, 22 cases (39.3 %) showed focal positive staining, and 29 cases (51.8 %) showed diffuse positive staining. In the non-serous group, 8 cases (30.8 %) showed negative staining and 18 cases (69.2 %) showed positive focal. No cases showed diffuse positive staining. In control group, 15 cases (83.3 %) showed negative staining and 3 cases (16.7 %) showed focal positive staining. No cases showed diffuse positive staining. There was significant difference between serous and non-serous, serous and control as well as nonserous and control. In the low-grade group, 1 case (10.6 %) showed negative staining, 17 cases (89.4 %) showed positive focal staining, and no cases showed diffuse positive staining. In high-grade group, 4 cases (5.5 %) showed negative staining, 5 cases (18.2 %) showed focal positive staining, and 29 cases (76.3 %) showed diffuse positive staining. Conclusion and recommendations We concluded that fallopian tube could be a site of origin of pelvic carcinoma. We recommend that risky females after completion of their family size should undergo prophylactic salpingectomy to reduce risk of pelvic cancers.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] High-Grade Ovarian Serous Carcinoma Presenting as Androgenetic Alopecia
    Eversman, Anna
    Tracey, Elisabeth
    Warren, Christine B.
    CUTIS, 2020, 106 (06): : E12 - E14
  • [42] EVALUATION OF A CASE WITH RECURRENT HIGH-GRADE SEROUS OVARIAN CARCINOMA
    Arik, Z.
    Cetinkaya, N.
    Gungor, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1313 - 1314
  • [43] Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
    Stur, Elaine
    Corvigno, Sara
    Xu, Mingchu
    Chen, Ken
    Tan, Yukun
    Lee, Sanghoon
    Liu, Jinsong
    Ricco, Emily
    Kraushaar, Daniel
    Castro, Patricia
    Zhang, Jianhua
    Sood, Anil K.
    ISCIENCE, 2022, 25 (03)
  • [44] Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
    Chen, Gregory M.
    Kannan, Lavanya
    Geistlinger, Ludwig
    Kofia, Victor
    Safikhani, Zhaleh
    Gendoo, Deena M. A.
    Parmigiani, Giovanni
    Birrer, Michael
    Haibe-Kains, Benjamin
    Waldron, Levi
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 5037 - 5047
  • [45] Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
    Kurman, R. J.
    ANNALS OF ONCOLOGY, 2013, 24 : 16 - 21
  • [46] Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
    Bromley, Amy B.
    Altman, Alon D.
    Chu, Pamela
    Nation, Jill G.
    Nelson, Gregg S.
    Ghatage, Praful
    Kalloger, Steve E.
    Han, Guangming
    Koebel, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (05) : 397 - 404
  • [47] The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
    Katsakhyan, Levon
    Baraban, Ezra G.
    Dumoff, Kimberly L.
    Burger, Robert A.
    Parikh, Rupal
    Cooper, Kumarasen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (02) : 175 - 179
  • [48] Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
    Byun, Jung Mi
    Cho, Hwa Jin
    Lee, Dae Sim
    Yoon, Hye Kyoung
    Kim, Young Nam
    Im, Do Hwa
    Kim, Da Hyun
    Lee, Kyung Bok
    Sung, Moon Su
    Jeong, Dae Hoon
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2023, 62 (01): : 107 - 111
  • [49] Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer
    Xiang, Li
    Rong, Guohua
    Zhao, Jing
    Wang, Zhenyan
    Shi, Fengfeng
    ONCOLOGY LETTERS, 2018, 15 (05) : 7769 - 7775
  • [50] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385